Chimeric antigen receptor therapy characterization assays and uses thereof
KASSIM SADIK (US)
Xue qiong (US)
NOVARTIS AG (CH)
UNIV PENNSYLVANIA (US)
- Priority:2018/04/12
KASSIM SADIK (US)
Xue qiong (US)
NOVARTIS AG (CH)
UNIV PENNSYLVANIA (US)
A61K35/17 (inventive, first)
C07K16/28 (inventive)
C12N5/0783 (inventive)
G01N33/50 (inventive)
A61P35/02 (inventive)
C07K2319/03
C07K2319/33
C07K16/2803 (inventive)
C07K2317/622
A61P35/02 (inventive, first)
C12N2501/999
G01N2800/52
C07K2319/30
G01N33/5005 (inventive)
A61K35/17 (inventive, first)
C12N5/0636 (inventive)
A61K39/4631 (inventive)
A61K39/4611 (inventive)
A61K39/464412 (inventive)
A61K2239/48 (inventive)
- US-10829735-B2 (APP)
- US-10851166-B2 (APP)
- US-10927184-B2 (APP)
- US-11026976-B2 (APP)
- US-11028143-B2 (APP)
- US-11084880-B2 (APP)
- CN-113238058-A (A) (SEA)
- US-11149076-B2 (APP)
- US-11161907-B2 (APP)
- US-11459390-B2 (APP)
- US-11512139-B2 (SEA)
- US-11542488-B2 (APP)
- US-11549099-B2 (APP)
- US-11578130-B2 (APP)
- US-11591404-B2 (APP)
- US-11608382-B2 (APP)
- US-11667691-B2 (APP)
- US-11747346-B2 (APP)
- US-11851659-B2 (APP)
- US-11865167-B2 (APP)
- US-11872249-B2 (APP)
- US-11896614-B2 (APP)
- US-RE49847-E (APP)
- US-11919946-B2 (APP)
- US-11939389-B2 (APP)
- US-11952428-B2 (APP)
- US-11975026-B2 (APP)
- US-11999802-B2 (APP)
- US-12037583-B2 (APP)
- Google PatentsLICENSE"Google Patents Research Data" by Google, based on data provided by IFI CLAIMS Patent Services and OntoChem, is licensed under a Creative Commons Attribution 4.0 International License.https://creativecommons.org/licenses/by/4.0/legalcode
- PubChem